| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 68.5% | 70.1% | ▲ +1.6% |
| Healthcare Services | 29.1% | 26.6% | ▼ -2.5% |
| Healthcare Equipment & Supplies | 0.6% | 0.6% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.1% | 71.2% | ▲ +1.1% |
| Healthcare Services | 26.6% | 26.9% | ▲ +0.3% |
| Healthcare Equipment & Supplies | 0.6% | 0.6% | ● +0.0% |
Comparing Apr 2026 → May 2026
| # | Stock | Sector | Weight (May 2026) |
|---|---|---|---|
| 1 | Zydus Lifesciences Limited ₹59.15 Cr |
Pharmaceuticals & Biotechnology | 2.50% |
| 2 | Biocon Limited ₹31.43 Cr |
Pharmaceuticals & Biotechnology | 1.33% |
| # | Stock | Sector | Last Weight (Apr 2026) |
|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹45.97 Cr |
Pharmaceuticals & Biotechnology | 2.13% |
| # | Stock | Sector | Apr 2026 | May 2026 | Change |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited ₹217.44 Cr |
Pharmaceuticals & Biotechnology | 8.05% | 9.20% | +1.15% |
| 2 | Neuland Laboratories Limited ₹70.43 Cr |
Pharmaceuticals & Biotechnology | 1.97% | 2.98% | +1.01% |
| 3 | Global Health Limited ₹72.76 Cr |
Healthcare Services | 2.21% | 3.08% | +0.87% |
| 4 | Wockhardt Limited ₹57.55 Cr |
Pharmaceuticals & Biotechnology | 1.67% | 2.44% | +0.77% |
| 5 | Cipla Limited ₹116.29 Cr |
Pharmaceuticals & Biotechnology | 4.27% | 4.92% | +0.65% |
| 6 | Novartis India Limited ₹15.10 Cr |
Pharmaceuticals & Biotechnology | 0.10% | 0.64% | +0.54% |
| 7 | Acutaas Chemicals Ltd ₹106.19 Cr |
Pharmaceuticals & Biotechnology | 4.07% | 4.50% | +0.43% |
| 8 | Laurus Labs Limited ₹74.82 Cr |
Pharmaceuticals & Biotechnology | 2.80% | 3.17% | +0.37% |
| 9 | Shilpa Medicare Ltd ₹53.92 Cr |
Pharmaceuticals & Biotechnology | 2.04% | 2.28% | +0.24% |
| 10 | Thyrocare Technologies Limited ₹36.41 Cr |
Healthcare Services | 1.33% | 1.54% | +0.21% |
| # | Stock | Sector | Apr 2026 | May 2026 | Change |
|---|---|---|---|---|---|
| 1 | Glenmark Pharmaceuticals Limited ₹77.55 Cr |
Pharmaceuticals & Biotechnology | 6.06% | 3.28% | -2.78% |
| 2 | IPCA Laboratories Limited ₹82.58 Cr |
Pharmaceuticals & Biotechnology | 4.39% | 3.50% | -0.89% |
| 3 | Max Healthcare Institute Limited ₹124.37 Cr |
Healthcare Services | 5.93% | 5.26% | -0.67% |
| 4 | Lupin Limited ₹128.87 Cr |
Pharmaceuticals & Biotechnology | 6.07% | 5.45% | -0.62% |
| 5 | Divi's Laboratories Limited ₹189.40 Cr |
Pharmaceuticals & Biotechnology | 8.56% | 8.02% | -0.54% |
| 6 | Anthem Biosciences Limited ₹98.16 Cr |
Pharmaceuticals & Biotechnology | 4.55% | 4.15% | -0.40% |
| 7 | Alkem Laboratories Limited ₹103.08 Cr |
Pharmaceuticals & Biotechnology | 4.69% | 4.36% | -0.33% |
| 8 | Fortis Healthcare Limited ₹80.49 Cr |
Healthcare Services | 3.71% | 3.41% | -0.30% |
| 9 | Aster DM Healthcare Limited ₹122.44 Cr |
Healthcare Services | 5.46% | 5.18% | -0.28% |
| 10 | Bajaj Healthcare Limited ₹17.19 Cr |
Pharmaceuticals & Biotechnology | 0.85% | 0.73% | -0.12% |
32 stocks — May 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹217.44 Cr |
Pharmaceuticals & Biotechnology |
9.20%
|
|
| 2 |
₹189.40 Cr |
Pharmaceuticals & Biotechnology |
8.02%
|
|
| 3 |
₹128.87 Cr |
Pharmaceuticals & Biotechnology |
5.45%
|
|
| 4 |
₹124.37 Cr |
Healthcare Services |
5.26%
|
|
| 5 |
₹122.44 Cr |
Healthcare Services |
5.18%
|
|
| 6 |
₹116.29 Cr |
Pharmaceuticals & Biotechnology |
4.92%
|
|
| 7 |
₹106.19 Cr |
Pharmaceuticals & Biotechnology |
4.50%
|
|
| 8 |
₹103.08 Cr |
Pharmaceuticals & Biotechnology |
4.36%
|
|
| 9 |
₹98.16 Cr |
Pharmaceuticals & Biotechnology |
4.15%
|
|
| 10 |
₹82.58 Cr |
Pharmaceuticals & Biotechnology |
3.50%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.